Log on / register
Feedback | Support | My details
Drotrecogin alfa (activated): real-life use and outcomes for the UK.
Rowan KM, Welch CA, North E, Harrison DA
Crit Care 2008, 12:R58
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies.
Altaweel L, Sweeney D, Cui X, Barochia A, Natanson C, Qeichacker P
Biologics 2009, 3:391-406
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 1 article in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.